LiveActive security incident?Get immediate response
CVE Record

CVE-2022-37016: Symantec Endpoint Protection (Windows) agent may be susceptible to a Privilege Escalation vulnerability, wh...

Symantec Endpoint Protection (Windows) agent may be susceptible to a Privilege Escalation vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.

CriticalCVSS 9.8Not KEV-listedUpdated
Glexia's TakeAutomated analysiscritical

Security readout for executives and security teams

Plain-English summary

This is a critical Symantec Endpoint Protection Windows agent issue that could let an attacker gain elevated access to protected system resources. The bundle identifies version 14.3 RU5 as affected. Because endpoint security agents run with high trust, successful exploitation could have broad business impact on compromised Windows systems.

Executive priority

Prioritize this for rapid assessment and remediation planning. A critical flaw in endpoint security software can undermine systems that businesses rely on for protection, even though this bundle does not confirm active exploitation or provide detailed fixes.

Technical view

CVE-2022-37016 is described as a privilege escalation vulnerability in the Symantec Endpoint Protection Windows agent. The supplied CVSS 3.1 score is 9.8 with AV:N/AC:L/PR:N/UI:N and high confidentiality, integrity, and availability impact. The available bundle does not include CWE details or vendor remediation specifics.

Likely exposure

Organizations are most likely exposed where Symantec Endpoint Protection 14.3 RU5 Windows agents are deployed. The CVSS vector indicates network attackability without privileges or user interaction, but validation should rely on Broadcom guidance and asset inventory because the bundle is sparse.

Exploitation context

The source bundle does not show CISA KEV listing and provides no cited evidence of active exploitation. Treat this as high urgency because of the critical CVSS score and privileged endpoint-agent context, not because exploitation is confirmed.

Researcher notes

Key gaps remain: no CWE, no exploit evidence, and no remediation details are included in the supplied bundle. The apparent privilege escalation description and network CVSS vector should be checked against Broadcom’s advisory before drawing conclusions about attack path.

Mitigation direction

  • Identify Windows endpoints running Symantec Endpoint Protection 14.3 RU5.
  • Review Broadcom advisory 21014 for fixed versions, workarounds, and supported upgrade paths.
  • Prioritize remediation on internet-exposed, shared, and high-value Windows systems.
  • Monitor Broadcom updates because the provided bundle does not name a specific fix.
  • Use compensating controls around endpoint management access until vendor remediation is confirmed.

Validation and detection

  • Query endpoint inventory for Symantec Endpoint Protection Windows agent versions.
  • Confirm whether any systems report version 14.3 RU5.
  • Compare installed versions against Broadcom advisory 21014 guidance.
  • Review endpoint security logs for suspicious privilege or service activity.
  • Document remediation status for all affected Windows assets.
Prepared
Confidence
medium
Sources
3

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

description · low confidence lookup

Privilege behavior lookup

The CVE wording references privilege impact, so privilege escalation and authorization behavior review may help. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2022-37016 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Critical
CVSS
9.8 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
9.8CVSS 3.1CriticalCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H3.95.9Primary CVE score

Vulnerability scoring details

Base CVSS 3.1 score

9.8Critical
CVSS 3.1 vector shape for CVE-2022-37016Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone
Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
n/aSymantec Endpoint Protection14.3 RU5Listed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.